Trials / Conditions / Bacterial Vaginosis

Bacterial Vaginosis

144 registered clinical trials studyying Bacterial Vaginosis — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Impact of Clinician-administered Vaginal Live Biotherapeutic Product NCT07305844	Caroline Mitchell	EARLY_Phase 1
Not Yet Recruiting	Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients NCT07483671	Chengdu Syncor Pharmaceutical Co., Ltd.	Phase 2
Not Yet Recruiting	Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis NCT07527572	Kaneka Americas Holding Inc.	Phase 2 / Phase 3
Not Yet Recruiting	The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study NCT05434104	Guy's and St Thomas' NHS Foundation Trust	N/A
Not Yet Recruiting	A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healt NCT07302035	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 1
Recruiting	Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections NCT07234786	Karo Pharma AB	N/A
Completed	Light Treatment of Vaginal Infections in Reproductive Age Women NCT06985433	UVISA Health ApS	N/A
Completed	Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial NCT06975436	Hoffmann-La Roche	—
Recruiting	Clinical Protocol CERN Feasibility Study NCT06933420	Cern Corporation	N/A
Not Yet Recruiting	A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associ NCT06665126	Happy V	N/A
Completed	A Clinical Study to Determine the Safety and Efficacy of an Oral Probiotic Supplementation to Improve Bacteria NCT06486103	NovoBliss Research Pvt Ltd	N/A
Not Yet Recruiting	Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth NCT06349122	Assistance Publique Hopitaux De Marseille	Phase 4
Not Yet Recruiting	Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection NCT06450990	NEXBIOME THERAPEUTICS	Phase 1 / Phase 2
Completed	A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multipl NCT06469164	BioNTech SE	Phase 1
Completed	Point of Care Diagnosis of Vaginal Infections NCT06438575	Sharon L Hillier	N/A
Recruiting	Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age NCT06458543	I.M. Sechenov First Moscow State Medical University	Phase 4
Enrolling By Invitation	Vaginal Ecosystem and Network in the United States Study NCT06472765	Vaginal Biome Science	—
Unknown	Effect of PreforPro® on Urinary and Vaginal Health NCT05590195	Jeremy Burton	Phase 3
Completed	A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health. NCT06516757	Love Wellness	N/A
Recruiting	Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis NCT06263465	Zhujiang Hospital	N/A
Completed	Vaginal lIve Biotherapeutic RANdomized Trial NCT06135974	Massachusetts General Hospital	EARLY_Phase 1
Completed	Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views NCT06154239	Anne's Day Ltd	N/A
Completed	Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidaz NCT07247851	Ain Shams Maternity Hospital	N/A
Recruiting	Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome NCT05753813	Queen's Medical Center	EARLY_Phase 1
Completed	A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult W NCT06123299	Gedea Biotech AB	N/A
Active Not Recruiting	Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pa NCT06616168	Danylo Halytsky Lviv National Medical University	Phase 1
Completed	Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiot NCT05796921	Agnese Maria Chiara Rapisarda	N/A
Completed	Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome NCT05701722	Vaginal Biome Science	N/A
Active Not Recruiting	Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs NCT05666778	Rush University Medical Center	Phase 2
Completed	Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb) NCT07418918	Guangdong Longchuangji Pharmaceutical Co., Ltd.	Phase 2
Unknown	Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healt NCT05587283	AtoGen Co. Ltd	Phase 1
Withdrawn	Serial Screening and Treatment of Bacterial Vaginosis Trial NCT05278130	Loma Linda University	N/A
Recruiting	The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantati NCT05963711	Hadassah Medical Organization	N/A
Unknown	First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories NCT05340790	Protelight Pharmaceuticals Australia PTY LTD	Phase 1
Completed	Performance and Safety of Lactal Gel for Treatment of Bacterial Vaginosis NCT07241871	Rolf Kullgren AB	N/A
Withdrawn	Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) NCT03769688	Johns Hopkins University	Phase 1
Unknown	A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and NCT05060029	Vedic Lifesciences Pvt. Ltd.	Phase 4
Completed	Flourish HEC to Prevent Recurrence of BV NCT05386147	Vaginal Biome Science	N/A
Completed	Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis NCT05211921	Karo Pharma AB	N/A
Terminated	Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis NCT05788991	Medinova AG	Phase 4
Completed	Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis NCT03734523	Vaginal Biome Science	—
Completed	Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis NCT05652959	Perfect Care Distribution	—
Completed	Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition NCT05022212	University of California, San Francisco	Phase 2
Completed	Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Af NCT06131749	University of Bern	—
Completed	Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions NCT04219605	Meir Medical Center	—
Completed	Pharmacokinetic Study of DARE-BV1 NCT05354050	Daré Bioscience, Inc.	Phase 1
Active Not Recruiting	Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with NCT06592976	University of Roma La Sapienza	N/A
Completed	Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule NCT06056947	Ege University	Phase 3
Completed	DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE) NCT04370548	Daré Bioscience, Inc.	Phase 3
Recruiting	A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis NCT04771728	Peking University Shenzhen Hospital	Phase 4
Completed	Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis NCT04640922	Gedea Biotech AB	N/A
Completed	Suppression Of Bacterial Vaginosis (BV) [SUBVert] NCT03930745	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Evaluation of Efficacy and Safety of Gynomax® XL Ovule NCT03839875	Exeltis Turkey	Phase 4
Completed	Probiotics as Adjuvant Treatment for Bacterial Vaginosis NCT03894813	Peking University Shenzhen Hospital	Phase 4
Completed	Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis NCT03762083	Gedea Biotech AB	N/A
Completed	Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis NCT03601429	Vesale Pharmaceutica	N/A
Completed	The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis NCT02905890	London School of Hygiene and Tropical Medicine	Phase 4
Completed	PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" NCT03187457	Danisco	N/A
Completed	Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis NCT03099408	Peking University Shenzhen Hospital	Phase 4
Completed	Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis NCT03116789	GenMont Biotech Incorporation	N/A
Completed	Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial NCT03091777	Balmoral Medical company	Phase 3
Terminated	Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women NCT02946346	University Hospital, Montpellier	N/A
Completed	A Study of the New Medical Device Polybactum® NCT02863536	Effik Italia S.p.A.	N/A
Completed	TOL-463 Phase 2 Study for Vaginitis NCT02866227	Toltec Pharmaceuticals, LLC	Phase 2
Completed	Women's Improvement of Sexual Health (WISH) Demonstration Project NCT03045809	Janneke van de Wijgert	—
Unknown	The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial NCT03080740	Guangzhou Yipinhong Pharmaceutical CO.,LTD	Phase 4
Completed	LACTIN-V Study for Recurrent Bacterial Vaginosis NCT02766023	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity NCT02445989	University of Washington	Phase 4
Completed	Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Va NCT02709005	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Unknown	Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis NCT03357666	Haudongchun Co., Ltd.	Phase 2
Completed	Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity NCT02432404	University of Washington	Phase 4
Unknown	Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fu NCT02186145	Marjan Industria e Comercio ltda	Phase 3
Completed	Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology NCT02527941	University of Toronto	Phase 1
Completed	Rwanda Vaginal Microbiota Restoration Study NCT02459665	Janneke van de Wijgert	N/A
Completed	Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219 NCT02452866	Symbiomix Therapeutics	Phase 3
Completed	A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis NCT02418845	Symbiomix Therapeutics	Phase 3
Terminated	Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis NCT02376972	Alfasigma S.p.A.	Phase 2
Completed	Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis NCT02744638	Clinical Research Center Kiel GmbH	N/A
Completed	Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) NCT02237950	Starpharma Pty Ltd	Phase 3
Completed	Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) NCT02236156	Starpharma Pty Ltd	Phase 3
Unknown	Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis NCT02185456	Wayne State University	EARLY_Phase 1
Completed	Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis NCT02203942	University of Pittsburgh	—
Unknown	Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis NCT02173184	Amvac Kft.	Phase 3
Completed	Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida NCT02295579	Skaraborg Hospital	—
Completed	Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Ba NCT02042287	Insel Gruppe AG, University Hospital Bern	Phase 4
Completed	A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis NCT02147899	Symbiomix Therapeutics	Phase 2
Completed	BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study NCT00799214	University of British Columbia	Phase 2 / Phase 3
Completed	A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Labor NCT02210689	Actavis Inc.	Phase 3
Completed	PNA FISH, PCR and Gram Staining for Detection of Bacterial Vaginosis - a Comparative Clinical Study in a Danis NCT02042352	Regionshospitalet Viborg, Skive	—
Completed	Bacterial Vaginosis Carriage in Early Pregnancy and Preterm Delivery in Martinique, F.W.I NCT03303859	University Hospital Center of Martinique	—
Completed	Clindamycin to Reduce Preterm Birth in a Low Resource Setting NCT01800825	Christiana Care Health Services	Phase 4
Recruiting	Prospective Data Bank Creation to Study Vaginal Conditions NCT01829204	Texas Tech University Health Sciences Center	—
Unknown	Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis NCT01841411	Minia University	Phase 4
Terminated	GoldenCareTM for the Treatment of Bacterial Vaginosis NCT01762670	CDA Research Group, Inc.	Phase 1 / Phase 2
Completed	Role of Oral Lactobacilli on Vaginal Flora of Pregnant Women NCT04638257	The University of Texas Medical Branch, Galveston	Phase 1
Completed	Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Wo NCT02150655	Western University, Canada	EARLY_Phase 1
Completed	Safety and Efficacy Study to Treat Bacterial Vaginosis NCT01621399	Medicis Global Service Corporation	Phase 3
Completed	A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis NCT01577537	Starpharma Pty Ltd	Phase 3
Completed	A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis NCT01577238	Starpharma Pty Ltd	Phase 3
Completed	Vitamin D and Sexual Health NCT01450462	Ohio State University	N/A
Completed	Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in NCT01230814	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue NCT01347632	CONRAD	N/A
Unknown	Effect of Different Courses of Lactobacilli Treatment on Bacterial Vaginosis and Pregnancy Outcomes NCT01421615	The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine	Phase 1
Completed	Observational Program Neo-Penotran® Forte NCT01335373	Bayer	—
Completed	Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) NCT01201057	Starpharma Pty Ltd	Phase 2
Unknown	Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion NCT01152528	Common Sense	Phase 3
Unknown	A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis NCT01089348	Avva Rus, JSC	Phase 2 / Phase 3
Completed	Lcr35® for Bacterial Vaginosis Prevention NCT01160796	Laboratoires Lyocentre	Phase 3
Completed	The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vagino NCT01258556	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2 / Phase 3
Completed	Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis NCT01471457	University of New Mexico	Phase 2 / Phase 3
Unknown	Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy NCT01558388	Università degli Studi di Brescia	Phase 4
Unknown	Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of M NCT00889356	Zodiac Produtos Farmaceuticos S.A.	Phase 3
Completed	Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis NCT01993524	IBSS Biomed S.A.	N/A
Withdrawn	Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women NCT00682721	University of Pittsburgh	N/A
Completed	Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System. NCT00752193	University Ghent	N/A
Completed	Bacterial Vaginosis Home Screening to Prevent STDs NCT00667368	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3
Completed	A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test NCT00682851	University of Pittsburgh	—
Terminated	Prevention of Persistence of Bacterial Vaginosis NCT00741845	Embil Pharmaceutical Co. Ltd	Phase 3
Completed	Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis NCT00635622	Osel, Inc.	Phase 2
Completed	Bacterial Vaginosis Screening at IUD Insertion NCT00802386	Unity Health Toronto	—
Completed	Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study NCT00464542	University of Pittsburgh	Phase 4
Completed	Safety Study of Lactobacillus Administered Vaginally to Healthy Women NCT00537576	Osel, Inc.	Phase 1
Unknown	The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients NCT00536848	National Institute for Medical Research, Tanzania	Phase 2 / Phase 3
Completed	Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study NCT00510614	University of Pittsburgh	EARLY_Phase 1
Completed	Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis NCT00556179	Sanofi	Phase 4
Completed	Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial NCT00545181	Indiana University School of Medicine	N/A
Completed	Treatment of Bacterial Vaginosis Combined With Human Lactobacilli NCT01245322	Skaraborg Hospital	Phase 4
Completed	Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing NCT00799500	Montse Palacio	N/A
Completed	Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg and the Effect on Spontaneous Preterm Deliver NCT02348463	Skaraborg Hospital	—
Completed	Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Va NCT01125410	Medinova AG	Phase 3
Completed	The Effects of Cranberry Juice on Bacterial Adhesion NCT00318253	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	Inflammation and Treatment of Bacterial Vaginosis Near Term NCT00720291	Medical University of South Carolina	N/A
Terminated	Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity NCT00303082	Oswaldo Cruz Foundation	Phase 3
Withdrawn	Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery NCT00217308	Mount Sinai Hospital, Canada	Phase 1
Completed	Treatment of Bacterial Vaginosis With Oral Tinidazole NCT00229216	Mission Pharmacal	Phase 3
Completed	Treatment of Bacterial Vaginosis (BV) With Tinidazole NCT00334633	University of Alabama at Birmingham	Phase 4
Completed	Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women NCT00207480	Centers for Disease Control and Prevention	N/A
Completed	Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments NCT00313131	Université de Sherbrooke	Phase 3
Unknown	Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and t NCT00124878	Wawer, Maria J., M.D.	Phase 3
Completed	Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence NCT00542074	University of Washington	N/A
Completed	Perinatal Infections in Pakistan NCT00070746	NICHD Global Network for Women's and Children's Health	—
Completed	Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi NCT00140764	Johns Hopkins Bloomberg School of Public Health	Phase 3
Completed	Treatment of Bacterial Vaginosis NCT00324818	University of Alabama at Birmingham	Phase 4
Completed	Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis NCT01020396	Teva Pharmaceuticals USA	Phase 1 / Phase 2